These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16434341)

  • 1. Epigastric pain.
    Phillips RA; Nadel ES; Brown DF
    J Emerg Med; 2006 Jan; 30(1):81-4. PubMed ID: 16434341
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
    Laghate VD; Gupta SB
    J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal effects of valproic acid?
    Garland EJ; Behr R
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproate and polycystic ovaries.
    Irwin M; Masand P
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):9-10. PubMed ID: 9444888
    [No Abstract]   [Full Text] [Related]  

  • 5. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

  • 6. A rare occurrence of isolated neutropenia with valproic acid: a case report.
    Chakraborty S; Chakraborty J; Mandal S; Ghosal MK
    J Indian Med Assoc; 2011 May; 109(5):345-6. PubMed ID: 22187773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergenyl chronospheres in bipolar disorders].
    Grunze H
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515285
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inadequate vasopressin secretion and valproate].
    Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
    Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-induced tinnitus misinterpreted as psychotic symptoms.
    Reeves RR; Mustain DW; Pendarvis JE
    South Med J; 2000 Oct; 93(10):1030-1. PubMed ID: 11147471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid-induced eosinophilic pleural effusion in a patient with pediatric bipolar disorder.
    Aral A; Usta MB; Karabekiroglu K
    Asia Pac Psychiatry; 2017 Sep; 9(3):. PubMed ID: 28856844
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Hyperkalemia Following Valproic Acid Use in an Elderly Patient With Late-Onset Mania.
    Kuo YC; Lin YC; Chen PH
    J Clin Psychopharmacol; 2016 Aug; 36(4):394-5. PubMed ID: 27182840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Ladwig J; Andreae D; Grohmann R; Toto S; Kropp S; Bleich S
    Pharmacopsychiatry; 2017 Nov; 50(6):270. PubMed ID: 28482360
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
    Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS
    Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
    [No Abstract]   [Full Text] [Related]  

  • 16. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent acute pancreatitis associated with valproic acid use for mood stabilization.
    Fecik SE; Stoner SC; Raphael J; Lindsey C
    J Clin Psychopharmacol; 1999 Oct; 19(5):483-4. PubMed ID: 10505598
    [No Abstract]   [Full Text] [Related]  

  • 18. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A; Siddu A; Sardu C; Sarnicola A; Martinelli V
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulminant hepatic failure in the context of reinstituting valproate use.
    Rej S; Chen T; Edwards M; Zicherman V
    Psychosomatics; 2014; 55(3):303-4. PubMed ID: 24360531
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.